Investigation on quinoxalinone substituted Pyrrolizine derivative a dual inhibitor of AKT and ERK signaling on overriding chemoresistance and EMT in Colorectal Cancer in a MACC1 dependent manner

dc.contributor.guide	Anindya Goswami
dc.coverage.spatial
dc.creator.researcher	Tanzeeba Amin
dc.date.accessioned	2025-03-28T09:43:53Z
dc.date.available	2025-03-28T09:43:53Z
dc.date.awarded	2025
dc.date.completed	2025
dc.date.registered	2020
dc.description.abstract	newline
dc.description.note
dc.format.accompanyingmaterial	None
dc.format.dimensions
dc.format.extent	ALL
dc.identifier.researcherid
dc.identifier.uri	http://hdl.handle.net/10603/630722
dc.language	English
dc.publisher.institution	Biological Sciences (CSIR-IIIM)
dc.publisher.place	Ghaziabad
dc.publisher.university	Academy of Scientific and Innovative Research (AcSIR)
dc.relation
dc.rights	university
dc.source.university	University
dc.subject.keyword	Biology
dc.subject.keyword	Biology and Biochemistry
dc.subject.keyword	Life Sciences
dc.title	Investigation on quinoxalinone substituted Pyrrolizine derivative a dual inhibitor of AKT and ERK signaling on overriding chemoresistance and EMT in Colorectal Cancer in a MACC1 dependent manner
dc.title.alternative	Investigation on quinoxalinone substituted Pyrrolizine derivative, a dual inhibitor of AKT and ERK signaling on overriding chemoresistance and EMT in Colorectal Cancer in a MACC1-dependent manner
dc.type.degree	Ph.D.